I-Tofacitnib Citrate

Incazelo emfushane:

Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
I-Tofacitnib Citrate I-Rheumatoid arthritis Endlini      


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

IMINININGWANE YOMKHIQIZO

Ingemuva

I-Tofacitinib citrate, eyaziwa nangokuthi i-CP-690550 citrate, iyi-inhibitor enamandla ye-janus kinase 3 (JAK3), i-tyrosine kinase ekhawulelwe ngamaseli e-hematopoetic ehilelekile ekudlulisweni kwesignali elawula ukusinda kwe-lymphocyte, ukwanda, ukuhlukaniswa, kanye ne-apoptosis. Ukuvinjelwa kuqondile nge-JAK3 ngokukhetha okuphindwe ka-1000 ngaphezu kwamanye ama-kinase omndeni angewona ama-JAK. Ngaphandle kokuvimbela i-JAKS (IC50 = 1 nM), i-tofacitinib citrate iphinde ivimbele i-janus kinase 2 (JAK2) kanye ne-janus kinase 1 (JAK1) enamandla angu-20- kanye ne-100 ngokuphindaphindiwe ngokulandelana. Nokho, ocwaningweni lwakamuva, izibopho ezibophezelayo (Ki) ze-tofacitinib citrate eziya ku-JAK1, JAK2, ne-JAK3 kubikwe ukuthi ziyi-1.6 nM, 21.7 nM, kanye ne-6.5 nM ngokulandelanayo.

Ireferensi

Lalitha Vijayakrishnan, R. Venkataramanan kanye noPalak Gulati. Ukwelapha ukuvuvukala nge-janus kinase inhibitor CP-690,550. Amathrendi ku-Pharmacological Science 2011: 32 (1); 25-34

Ukucaphuna Komkhiqizo

  • 1. Panagi I, Jennings E, et al. "I-Salmonella Effector SteE Iguqula i-Mammalian Serine/Threonine Kinase GSK3 ibe i-Tyrosine Kinase ukuze Iqondise I-Macrophage Polarization." I-Cell Host Microbe. 2020;27(1):41–53.e6. PMID:31862381
  • 2. McInnes IB, Byers NL, et al. "Ukuqhathaniswa kwe-baricitinib, upadacitinib, kanye ne-tofacitinib mediated regulation of cytokine signing in human leukocyte subpopulations." I-Arthritis Res Ther. 2019 Aug 2;21(1):183. PMID:31375130
  • 3. U-Liu S, u-Verma M, nabanye. "Ukumelana ne-Steroid yohlobo 2 lwamaseli e-lymphoid angaphakathi avela ezigulini ezine-asthma enzima: Indima ye-thymic stromal lymphopoietin." J Allergy Clin Immunol. 2018 Jan;141(1):257-268.e6. PMID:28433687
  • 4. UZheng, uLufeng, nabanye. "I-3′ UTR ye-pseudogene CYP4Z2P ikhuthaza i-tumor angiogenesis kumdlavuza webele ngokusebenza njenge-ceRNA ye-CYP4Z1." Ucwaningo nokwelashwa komdlavuza webele (2015): 1-14. PMID:25701119

Incazelo

I-Tofacitinib citrate iyi-JAK1/2/3 inhibitor etholakala ngomlomo ene-IC50s engu-1, 20, kanye no-112 nM, ngokulandelanayo. I-Tofacitinib citrate ine-antibacterial, antifungal kanye nemisebenzi ye-antiviral.

Isitoreji

4°C, vikela ekukhanyeni

*Ku-solvent : -80°C, izinyanga ezingu-6; -20°C, inyanga engu-1 (vikela ekukhanyeni)

 

Isakhiwo samakhemikhali

I-Tofacitnib Citrate

Idatha Yebhayoloji Ehlobene

I-Tofacitnib Citrate2

Idatha Yebhayoloji Ehlobene

I-Tofacitnib Citrate3

Idatha Yebhayoloji Ehlobene

I-Tofacitnib Citrate4

Idatha Yebhayoloji Ehlobene

I-Tofacitnib Citrate5

Idatha Yebhayoloji Ehlobene

I-Tofacitnib Citrate6

ISItifiketi

2018 GMP-2
原料药GMP证书201811 (captopril,thalidomide njll)
I-GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
I-FDA-EIR-Letter-201901

UKUPHATHWA KWEKHWALITHI

Ukuphathwa kwekhwalithi1

Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Ukuphathwa kwekhwalithi2

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Ukuphathwa kwekhwalithi3

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Ukuphathwa kwekhwalithi4

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.

UKUPHATHWA KOMKHIQIZO

cpf5
cpf6

I-Korea Countec Bottled Packaging Line

cpf7
cpf8

I-Taiwan CVC Bottled Packaging Line

cpf9
cpf10

I-Italy CAM Board Packaging Line

cpf11

Umshini Wokuhlanganisa we-Fette waseJalimane

cpf12

I-Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UZAkwethu

Ukubambisana kwamazwe ngamazwe
Ukubambisana kwamazwe ngamazwe
Ukubambisana kwasekhaya
Ukubambisana kwasekhaya

  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona